Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

IRIDEX CORP shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -7% YoY in Q2 FY2027.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -7% YoY in Q2 FY2027

Pipeline evidence · 0d ago

IRIX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on IRIX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2027

Full IRIX earnings analysis

Reported figures for IRIDEX CORP — research only, not investment advice.

Revenue YoY
-7.4%

Latest Intelligence

Updated

What happened recently for IRIDEX CORP (IRIX) — events, not interpretation.

Event
Reported Q2 2027 revenue -7% YoY.
Also
Last session September 28, 2026 at $0.62.
Source
Q2 2027 earnings

Research & analysis only — not investment advice.

Building company intelligence…

IRIDEX CORP (IRIX)

Healthcare · Electromedical & Electrotherapeutic Apparatus

Investment Snapshot above is the primary AlphaOS analysis for IRIDEX CORP — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$10.89M
Revenue:
$12.57M

IRIX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow IRIDEX CORP through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.